Early Inflammatory Biomarkers Associated With Functional Outcomes in Acute Cerebral Venous Thrombosis: CLOT-VENUS Substudy
Stroke · 2026
DOI: 10.1161/strokeaha.125.052774 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Stroke, 2026. Verfasst von Leonardo Cruz-Criollo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Iowa Health Care, Iowa City (L.C.-C., M.G.-C., A.R.-C., P.K., A.B., J.G., J.L., J.C., N.A., A.S.). Hauptthemen laut MEDLINE: Venous Thrombosis, Intracranial Thrombosis, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Inflammatory serum biomarkers, including neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII), are associated with outcomes in acute cerebrovascular diseases. However, their prognostic role in cerebral venous thrombosis remains uncertain. We aimed to assess the prognostic value of these biomarkers in acute cerebral venous thrombosis by identifying optimal thresholds and internally validating their predictive performance. METHODS: This retrospective observational cohort study included adults diagnosed with acute cerebral venous thrombosis from the international CLOT-VENUS registry (Collaboration on Cerebral Venous Thrombosis Study; 2004–2024), including 2 comprehensive stroke centers in the United States and Mexico. Biomarkers of interest (NLR, MLR, PLR, SII) were calculated from admission complete blood counts. The primary outcome was functional status at 6 months, measured by the modified Rankin Scale dichotomized as 0 to 2 versus 3 to 6. Secondary outcomes included modified Rankin Scale score at discharge and mortality. Associations were tested with multivariable logistic regression adjusted for clinically relevant covariates. Optimal biomarker cutoffs were identified using stratified bootstrap receiver operating characteristic analysis and internally validated with out-of-bag testing. RESULTS: Of 432 patients, 394 met the inclusion criteria, and complete data were available for 339 of those patients. Median age was 40 years [interquartile range, 27–45], and 65.2% were female. Elevated biomarkers at admission were associated with modified Rankin Scale score 3 to 6 at discharge and 6 months. At 6 months, optimal cutoff values for NLR ≥4.88 (adjusted odds ratio [aOR], 2.19; P =0.044), MLR ≥0.54 (aOR, 2.32; P =0.027), PLR ≥161.04 (aOR, 3.33; P =0.003), and SII ≥1388.58 (aOR, 2.03; P =0.049). Similar associations occurred at discharge using the same thresholds. PLR and SII notably predicted mortality at discharge (PLR aOR, 6.33; P =0.008, and SII aOR, 3.93; P =0.031) and at 6 months (PLR aOR, 7.19; P =0.004, and SII aOR, 4.69; P =0.010). CONCLUSIONS: Elevated admission levels of NLR, PLR, MLR, and SII are independently associated with poor discharge and 6-month outcomes in patients with acute cerebral venous thrombosis. These accessible biomarkers may aid early risk stratification. Further studies should validate and explore its usefulness in clinical models for personalized management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Iowa Health Care, Iowa City (L.C.-C., M.G.-C., A.R.-C., P.K., A.B., J.G., J.L., J.C., N.A., A.S.).
- Facultad de Medicina Humana, Universidad Cientifica del Sur, Lima, Peru (A.R.-C.).
- Stroke Clinic, Department of Neurology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City (V.C.-N., A.M., A.P.-C, A.A.).
- Doctoral Program in Medical Sciences, Faculty of Medicine, Universidad Nacional Autónoma de Mexico (UNAM), Mexico City (V.C.-N.).
- Department of Neurosciences, Hospital Dr. Rafael A. Calderon Guardia, San Jose, Costa Rica (M.A.B.).
- Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR (B.Z.-L.).
ORCID-Profile: Leonardo Cruz-Criollo, Milagros Galecio-Castillo, Aaron Rodriguez-Calienes, Piyush Kalakoti, Vanessa Cano-Nigenda, Miguel A Barboza, Adrian Pereda-Castillo, Jorge Cespedes, Nashwa Abdelhakim, Brian J Smith, Nicholas M Mohr, Antonio Arauz, Santiago Ortega-Gutierrez
Förderung
- NINDS NIH HHS
Zitieren
APA
Cruz-Criollo, L., Galecio-Castillo, M., Rodriguez-Calienes, A., Kalakoti, P., Cano-Nigenda, V., Brito, A., Barboza, M. A., Gao, J., Mercado, A., Pereda-Castillo, A., Lefkowitz, J., Cespedes, J., Abdelhakim, N., Zheng-Lin, B., Shaban, A., Smith, B. J., Mohr, N. M., Arauz, A., & Ortega-Gutierrez, S. (2026). Early Inflammatory Biomarkers Associated With Functional Outcomes in Acute Cerebral Venous Thrombosis: CLOT-VENUS Substudy. Stroke. https://doi.org/10.1161/strokeaha.125.052774
Vancouver
Cruz-Criollo L, Galecio-Castillo M, Rodriguez-Calienes A, Kalakoti P, Cano-Nigenda V, Brito A, et al. Early Inflammatory Biomarkers Associated With Functional Outcomes in Acute Cerebral Venous Thrombosis: CLOT-VENUS Substudy. Stroke. 2026. doi:10.1161/strokeaha.125.052774
BibTeX
@article{CruzCriollo2026,
author = {Cruz-Criollo, Leonardo and Galecio-Castillo, Milagros and Rodriguez-Calienes, Aaron and Kalakoti, Piyush and Cano-Nigenda, Vanessa and Brito, Anderson and Barboza, Miguel A and Gao, Jason and Mercado, Andres and Pereda-Castillo, Adrian and Lefkowitz, Jason and Cespedes, Jorge and Abdelhakim, Nashwa and Zheng-Lin, Binbin and Shaban, Amir and Smith, Brian J and Mohr, Nicholas M and Arauz, Antonio and Ortega-Gutierrez, Santiago},
title = {Early Inflammatory Biomarkers Associated With Functional Outcomes in Acute Cerebral Venous Thrombosis: CLOT-VENUS Substudy},
journal = {Stroke},
year = {2026},
doi = {10.1161/strokeaha.125.052774}
}
EUVIMED